Kumagai Kazuyuki, Furukawa Mariko, Ogino Nobuchika, Larson Eric, Iwaki Masayoshi, Tachi Naoko
Shinjo Ophthalmologic Institute, Miyazaki, Japan.
Retina. 2009 Apr;29(4):464-72. doi: 10.1097/IAE.0b013e31819c632f.
To report the long-term results of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
Interventional, retrospective, consecutive case series.
Clinical records of 332 consecutive patients (496 eyes) with diabetic macular edema without a thickened and taut posterior hyaloid on contact lens examination were reviewed. Four hundred eighty-six eyes of 326 consecutive patients were included in this study. All patients underwent pars plana vitrectomy with the creation of a posterior vitreous detachment by one surgeon. Simultaneous phacoemulsification with intraocular lens implantation was performed on 456 phakic eyes. Internal limiting membrane peeling was performed on 178 (36.6%) of 486 eyes. The main outcome measured was best-corrected visual acuity results during follow-up periods.
Postoperative follow-up ranged from 12 to 170 months (mean, 74.0 months). Five year follow-up data were available for 356 (71.8%) of 496 eyes. Mean preoperative best-corrected visual acuity significantly increased from 0.19 (20/105) to 0.32 (20/63) at 1 year after surgery (P < 0.0001), and 0.30 (20/67) at the final visit (P < 0.0001). The final best-corrected visual acuity improved in 256 (52.7%) of the 486 eyes, remained unchanged in 152 eyes (31.3%), and worsened in 78 eyes (16.0%). Postoperative major complications included neovascular glaucoma in 19 eyes (3.9%), recurrent vitreous hemorrhage in 10 eyes (2.1%), hard exudate deposits in the center of the macula in 21 eyes (4.2%), and glaucoma in 22 eyes (4.5%).
Pars plana vitrectomy with and without internal limiting membrane peeling appears to be beneficial in eyes with diffuse nontractional diabetic macular edema, and its effectiveness is maintained long term.
报告经平坦部玻璃体切除术治疗弥漫性非牵引性糖尿病性黄斑水肿的长期结果。
干预性、回顾性、连续病例系列。
回顾了332例(496只眼)经隐形眼镜检查后玻璃体后界膜未增厚和紧张的糖尿病性黄斑水肿患者的临床记录。本研究纳入了326例连续患者的486只眼。所有患者均由一名外科医生进行经平坦部玻璃体切除术并造成玻璃体后脱离。456只晶状体眼同时进行了超声乳化白内障吸除联合人工晶状体植入术。486只眼中的178只(36.6%)进行了内界膜剥除术。主要观察指标为随访期间的最佳矫正视力结果。
术后随访时间为12至170个月(平均74.0个月)。496只眼中的356只(71.8%)有5年随访数据。术后1年时,平均术前最佳矫正视力从0.19(20/105)显著提高至0.32(20/63)(P<0.0001),末次随访时为0.30(20/67)(P<0.0001)。486只眼中,256只(52.7%)的最终最佳矫正视力提高,152只眼(31.3%)保持不变,78只眼(16.0%)恶化。术后主要并发症包括新生血管性青光眼19只眼(3.9%)、复发性玻璃体出血10只眼(2.1%)、黄斑中心硬性渗出物沉积21只眼(4.2%)和青光眼22只眼(4.5%)。
有无内界膜剥除的经平坦部玻璃体切除术对弥漫性非牵引性糖尿病性黄斑水肿眼似乎有益,且其有效性可长期维持。